About CorTec

CorTec is a young medical engineering company focusing on innovations in the field of neurotechnology. With CorTec Brain Interchange we are developing a direct interface between brain and technology.

We are thinking ahead, developing tomorrow’s neurotechnology today.

It is our great strength that our technology derives from one single thought – from the basic idea up to its subsequent therapeutic use. This way, we create innovations regarding therapy, rehabilitation, and assistive technologies.

Our most important product is CorTec Brain Interchange, an implantable technology that measures and stimulates brain activity in long-term use.


CorTec Brain Interchange controls itself: The system measures the brain’s activity and thus the effect of its stimulation. It then aligns its further activities with the measured data.

Contrary to other neurotechnological implants currently on the market, CorTec Brain Interchange determines the respective therapeutic demand in direct communication with the brain and thus allows for a gentle treatment.

CorTec Brain Interchange consists of 3 components:

  1. Up to two multi-channel electrodes on the brain surface plus eventually two depth electrodes, connected with
  2. an intelligent implant that communicates via the skin with
  3. a software which reads the measured data and controls the application.

The electrode component oft he implant is at the same time our first product that we are already selling into the research market and also to other companies as subcomponent of their own products. CE and FDA approval are in preparation.


CorTec is a limited liability company that was founded in Freiburg, Germany, in September 2010. In summer of 2018 CorTec moved into new premises closeby the Airport Campus of the University of Freiburg including own clean room facilities. Thus, a continued growth of the company is ensured as well as the existing interconnection with science and research.

Press releases

1. August 2013

CorTec On The Way To The Future Of Neurotechnology: Company Closes Second Financing Round

Just two years after seed financing CorTec announces the closing of another round of investment. M-Invest and KfW banking group are now joining the round of investors engaged with CorTec. Their investment of three million Euro will support the market launch of AirRay, CorTec’s first product. Furthermore, the company plans to start into the clinical phase with the implant based on CorTec Brain Interchange technology. „With M-Invest we found a very active investor who gives us great support
10. October 2011

With CorTec the High-Tech Gründerfonds Invests In the Future of Neurotechnology

CorTec is developing a neurotechnological platform for measuring and stimulating of brain activity. With their seed investment High-Tech Gründerfonds, Seedfonds Baden-Württemberg and K & S W Invest are enabling the young company to go on with its development towards a clinical application of the platform system and to bring it to market maturity. „The platform character of our system opens up a wide variety of applications to us“, explains Dr. Jörn Rickert, one of the managing direc

Info & Contact


Neuer Messplatz 3
79108 Freiburg

In portfolio

12. Aug 2011

Marco Winzer